1.
An. bras. dermatol
;
93(6): 938-939, Nov.-Dec. 2018. graf
Article
in English
| LILACS
| ID: biblio-973636
Subject(s)
Humans , Female , Middle Aged , Telangiectasis/etiology , Breast Neoplasms/drug therapy , Drug Eruptions/etiology , Trastuzumab/adverse effects , Antineoplastic Agents, Immunological/adverse effects , Telangiectasis/pathology , Breast Neoplasms/chemistry , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Drug Eruptions/pathology , Receptor, ErbB-2 , Trastuzumab/therapeutic use , Antineoplastic Agents, Immunological/therapeutic use , Maytansine/analogs & derivatives , Maytansine/adverse effects , Maytansine/therapeutic use , Neoplasm Staging
2.
Indian J Dermatol Venereol Leprol
;
2014 Jan-Feb; 80(1): 92-93
Article
in English
| IMSEAR
| ID: sea-154780